Skip to main content

Table 2 Percentage of overall conclusion, presented separately for each discipline

From: A systematic review of moral reasons on orphan drug reimbursement

Discipline Overall assessment regarding special status
For special status Against special status Conditionally in favour Unclear Total
Philosophy/bioethics 13 (45%) 4 (14%) 8 (28%) 4 (14%) 29 (100%)
Clinical medicine 12 (57%) 2 (10%) 6 (29%) 1 (5%) 21 (100%)
Health economics 17 (35%) 6 (12%) 21 (43%) 5 (10%) 49 (100%)
Health policy 40 (39%) 11 (11%) 32 (31%) 20 (19%) 103 (100%)
Law 6 (67%) 0 (0%) 1 (11%) 2 (22%) 9 (100%)
Social sciences 2 (10%) 7 (35%) 10 (50%) 1 (5%) 20 (100%)
Industry (stakeholder) 2 (50%) 1 (25%) 1 (25%) 0 (0%) 4 (100%)
Patients (stakeholder) 3 (100%) 0 (0%) 0 (0%) 0 (0%) 3 (100%)
Other 2 (40%) 0 (0%) 3 (60%) 0 (0%) 5 (100%)
Total 97 (40%) 31 (13%) 82 (34%) 33 (14%) 243 (100%)